Physician profile
Ara Kelekian
NPI 1871598748
$7,041.78
in general payments reported to CMS, 2019-2025
27 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,711 · 2020: $906 · 2021: $682 · 2022: $1,245 · 2023: $1,108 · 2024: $883 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,497.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,405.35 | 2019-2025 | Stravix, Grafix Pl, Oasis |
| Cardiovascular Systems INC. | $484.76 | 2019-2022 | |
| Organogenesis INC. | $482.55 | 2019-2020 | |
| Cook Medical LLC | $285.31 | 2020-2021 | |
| Paragon 28, INC. | $284.13 | 2019-2023 | Monkey Rings, Portfolio |
| Melinta Therapeutics, LLC | $245.34 | 2019-2022 | |
| Horizon Therapeutics Plc | $233.45 | 2021-2022 | |
| Orthofix Medical, INC. | $205.38 | 2025 | Physio-Stim, Tl-Hex Truelok Hexapod System |
| Bioventus LLC | $163.54 | 2019-2021 | |
| Integra Lifesciences Corporation | $161.00 | 2019-2022 | |
| Kci USA, INC. | $157.65 | 2019-2021 | |
| Angiodynamics, INC. | $140.67 | 2022 | |
| Amgen INC. | $121.83 | 2024 | Krystexxa |
| Depuy Synthes Sales INC. | $119.31 | 2024-2025 | Minibunion, Hammerlock |
| Tei Medical INC. | $80.44 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $69.65 | 2019-2021 | |
| Nevro Corp. | $68.64 | 2023 | Senza |
| Tactile Systems Technology INC | $61.61 | 2019-2020 | |
| Amniox Medical, INC. | $53.16 | 2020 | |
| Wright Medical Technology, INC. | $44.33 | 2020 | |
| Stryker Corporation | $31.50 | 2021 | |
| Biotissue Holdings INC. | $30.50 | 2021-2023 | |
| Medline Industries LP | $27.27 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $23.17 | 2022 | |
| Misonix INC | $22.95 | 2019 | |
| Grt US Holding, INC. | $20.40 | 2022 | |
| Arthrosurface Incorporated | $17.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ara Kelekian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.